Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

L.R. Martins; P. Lúcio; A. Melão; I. Antunes; B.A. Cardoso; R. Stansfield; M.T.S. Bertilaccio; P. Ghia; D. Drygin; M.G. Silva; J.T. Barata

doi:10.1038/leu.2013.232

Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

L.R. Martins
, P. Lúcio
, A. Melão
, I. Antunes
, B.A. Cardoso
, R. Stansfield
, M.T.S. Bertilaccio
, P. Ghia
, D. Drygin
, M.G. Silva
, J.T. Barata

Research output: Contribution to journal › Letter › peer-review

68 Citations (Scopus)

Original language	English
Pages (from-to)	179-182
Number of pages	4
Journal	Leukemia
Volume	28
Issue number	1
DOIs	https://doi.org/10.1038/leu.2013.232
Publication status	Published - 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2013.232Licence: Other

Cite this

@article{0d307b0dd2fa4818b0cf3468827b3527,

title = "Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia",

author = "L.R. Martins and P. L{\'u}cio and A. Mel{\~a}o and I. Antunes and B.A. Cardoso and R. Stansfield and M.T.S. Bertilaccio and P. Ghia and D. Drygin and M.G. Silva and J.T. Barata",

year = "2014",

doi = "10.1038/leu.2013.232",

language = "English",

volume = "28",

pages = "179--182",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

AU - Martins, L.R.

AU - Lúcio, P.

AU - Melão, A.

AU - Antunes, I.

AU - Cardoso, B.A.

AU - Stansfield, R.

AU - Bertilaccio, M.T.S.

AU - Ghia, P.

AU - Drygin, D.

AU - Silva, M.G.

AU - Barata, J.T.

PY - 2014

Y1 - 2014

UR - https://www.scopus.com/pages/publications/84891855786

U2 - 10.1038/leu.2013.232

DO - 10.1038/leu.2013.232

M3 - Letter

SN - 0887-6924

VL - 28

SP - 179

EP - 182

JO - Leukemia

JF - Leukemia

IS - 1

ER -

Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

UN SDGs

Access to Document

Other files and links

Cite this